| 000 | 02675 a2200709 4500 | ||
|---|---|---|---|
| 005 | 20250514234631.0 | ||
| 264 | 0 | _c20050923 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2005.06.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Shu-Jing | |
| 245 | 0 | 0 |
_aEffects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cAug 2005 |
||
| 300 |
_a96-106 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aApoptosis Regulatory Proteins |
| 650 | 0 | 4 | _aApoptotic Protease-Activating Factor 1 |
| 650 | 0 | 4 | _aBH3 Interacting Domain Death Agonist Protein |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xmetabolism |
| 650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
| 650 | 0 | 4 | _aCaspase 3 |
| 650 | 0 | 4 | _aCaspase 8 |
| 650 | 0 | 4 | _aCaspase 9 |
| 650 | 0 | 4 | _aCaspase Inhibitors |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aCytochromes c _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Membranes _xdrug effects |
| 650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
| 650 | 0 | 4 |
_aIsothiocyanates _xpharmacology |
| 650 | 0 | 4 |
_aLiver Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aMitochondrial Proteins _xmetabolism |
| 650 | 0 | 4 |
_aOligopeptides _xpharmacology |
| 650 | 0 | 4 |
_aProteins _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aVitamin E _xpharmacology |
| 650 | 0 | 4 | _aX-Linked Inhibitor of Apoptosis Protein |
| 650 | 0 | 4 | _abcl-2-Associated X Protein |
| 650 | 0 | 4 |
_afas Receptor _xmetabolism |
| 700 | 1 | _aNg, Lean Teik | |
| 700 | 1 | _aLin, Chun-Ching | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 518 _gno. 2-3 _gp. 96-106 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2005.06.021 _zAvailable from publisher's website |
| 999 |
_c15707342 _d15707342 |
||